Rosh Internal Medicine Boost Practice Exam 2026 – The All-in-One Guide for Exam Success!

The first-line treatment for hypertension in a patient with diabetes is angiotensin-converting enzyme (ACE) inhibitors. This class of medication is particularly effective because it provides both blood pressure control and renal protective effects, which are crucial for diabetic patients who are at increased risk of developing diabetic nephropathy. ACE inhibitors work by inhibiting the conversion of angiotensin I to angiotensin II, leading to vasodilation and reduced blood pressure. Additionally, they help to decrease proteinuria, a common complication in diabetic patients, further protecting renal function.

In diabetic patients with hypertension, managing blood pressure effectively is essential, as uncontrolled hypertension can exacerbate diabetes complications. ACE inhibitors also have favorable effects on cardiovascular outcomes, making them ideal for this population. This is why guidelines often recommend ACE inhibitors as first-line treatment in diabetic patients with hypertension.

Other antihypertensive classes, while useful in certain situations, do not provide the same level of renal protection or are not specifically indicated as first-line therapies for this demographic. For example, calcium channel blockers, beta-blockers, and thiazide diuretics may be used in conjunction or as alternative agents, particularly if there are additional comorbidities or individual patient considerations, but they lack the dual benefits